Newstral
Teva
- European Commission’s First-Ever Abuse of Dominance Probe for Shelving of a Novel Pipeline Therapyjdsupra.com
- Alvotech and Teva’s Selarsdi™ (ustekinumab-aekn), Biosimilar to Stelara® Approved by FDAjdsupra.com
- FDA Approval of Alvotech/Teva Ustekinumab Biosimilarjdsupra.com
- Obviousness Analysis Does Not Consider Unclaimed Limitationsjdsupra.com
- Genentech and Dr. Reddy’s Settle BPCIA Litigation Against Proposed Rituxan Biosimilar DRL_RIjdsupra.com
- Patent Case Summaries | Week Ending April 5, 2024jdsupra.com
- Janssen v. Teva: Not an April Fool’s Day Joke for Life Sciences Companiesjdsupra.com
- Vanda Swings for the Fences and Asks the Supreme Court to Heighten the Standard for Obviousnessjdsupra.com
- Bill would increase penalty on EpiPen manufacturers for flouting Colorado’s price capDenver Post
- European Commission opens unprecedented abuse of dominance probe in animal medicines sectorjdsupra.com
- Avatar’s Paul Sun-Hyung Lee wants to geek out with the fans of the futureThe Verge
- Carrots and Sticks: DOJ’s Push to Incentivize Voluntary Disclosure of Corporate Misconduct (Part II of II)jdsupra.com
- TBiden, Sanders to take victory lap after drugmakers cap cost of inhalersthehill.com
- They escaped a world of fast fashion to teach L.A. how to give old clothes new lifeLA Times
- Biden FY25 HHS Budget Eliminates the Separate Interchangeability Designation for Biosimilarsjdsupra.com
- Biocon Settles with Janssen, Securing U.S. Market Entry Date for Ustekinumab Biosimilarjdsupra.com
- MLet’s talk about why you wear your Blundstonesmustangnews.net
- Teva and Alvotech’s Adalimumab Biosimilar Receives Interchangeable Status at FDAjdsupra.com
- First High-Concentration Humira® Interchangeable, Alvotech and Teva’s Simlandi®, Approved in the U.S.jdsupra.com
- Maryland announces $238 million in new opioid settlements with Walgreens, Walmart, two drugmakersbaltimoresun.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.